| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |